Skip to main content
    H

    Hyperion DeFi, Inc. (HYPD)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.47
    -0.11 (-4.26%)

    Market Cap: $39.84M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Hyperion DeFi, Inc. (HYPD) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Hyperion DeFi (HYPD) trades at 20.3x sales and 0.3x book value. Its P/B of 0.3x is below its 5-year median of 3.5x.

    Current Multiples

    Its enterprise value is 0.8x its EBITDA.

    MultipleValue
    P/E (trailing)N/A
    Forward P/EN/A
    Price to sales20.3x
    Price to book0.3x
    EV/EBITDA0.8x
    PEGN/A
    As of Nov 17, 2026

    Historical Medians

    MultipleCurrent5-year median10-year median
    P/B0.3x3.5xN/A
    Medians of month-end values through Oct 2026: 50 months (5-year).

    Valuation History

    Over the 7 of the 8 year ends shown that have a P/B, its P/B ranged from 0.6x in 2025 to 24.5x in 2021. 2025 was the lowest of those years.

    Year endPriceP/SP/B
    2025$3.5626.6x0.6x
    2024$11.68150.7xN/A
    2023$166.40N/A5.3x
    2022$130.40N/A2.8x
    2021$320.00N/A24.5x
    2020$484.80N/A7.2x
    2019$358.40N/A4.4x
    2018$228.00N/A1.4x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About HYPD

    Is HYPD stock overvalued?

    GNG's valuation label for HYPD is Undervalued.

    What is HYPD's price to sales ratio?

    Hyperion DeFi has a price to sales ratio of 20.3x.